Case-control analysis of SNPs in GLUT4, RBP4 and STRA6: Association of SNPs in STRA6 with type 2 diabetes in a south indian population

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Nair, Anup Kumar ^a   Sugunan, Divya ^a   Kumar, Harish ^b   Anilkumar, Gopalakrishnapillai ^a  

^a AMRITA UNIVERSITY   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; MEMBRANE PROTEIN; RETINOL BINDING PROTEIN 4; STIMULATED BY RETINOIC ACID GENE HOMOLOG 6; UNCLASSIFIED DRUG; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; SLC2A4 PROTEIN, HUMAN; STRA6 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETOGENESIS; DOWN REGULATION; ETHNICITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INDIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED;

TETRA;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TRANSPORTER TYPE 4; HAPLOTYPES; HUMANS; INDIA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINOL-BINDING PROTEINS, PLASMA;

EID: 77955374005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011444     Document Type: Article

References (41)

1. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM: A balanced overview. Diabetes Care 15: 318-368.
2. Consoli A (1992) Role of liver in pathophysiology of NIDDM. Diabetes Care 15(3): 430-441.
3. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362.
4. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733.
5. Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA, Zimmermann MB (2007) Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab 92: 4359-4365.
6. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
7. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T (2007) Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 92: 2712-2719.
8. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, et al. (2007) A membrane receptor for retinol binding protein mediates the cellular uptake of vitamin A. Science 315: 820-825.
9. White T, Lu T, Metlapally R, Katowitz J, Kherani F, et al. (2008) Identification of STRA6 and SKI sequence variants in patients with anophthalmia/microphthalmia. Mol Vis 14: 2458-2465.
10. Szeto W, Jiang W, Tice DA, Rubinfeld B, Hollingshead PG, et al. (2001) Overexpression ofthe retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res 61: 4197-4205.
11. Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, et al. (2007) Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet 120: 879-888.
12. Kovacs P, Geyer M, BerndtJ, Kloting N, Graham TE, et al. (2007) Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 56: 3095-3100.
13. Hu C, Jia W, Zhang R, Wang C, Lu J, et al. (2008) Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population. Diabet Med 25: 11-18.
14. Shea JL, Loredo-Osti JC, Sun G (2009) Association of RBP4 Gene Variants and Serum HDL Cholesterol Levels in the Newfoundland Population. Obesity (Silver Spring) 2009, In press.
15. O'Rahilly S, Krook A, Morgan R, Rees A, Flier JS, et al. (1992) Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population. Diabetologia 35(5): 486-489.
16. Choi WH, O'Rahilly S, Buse JB, Rees A, Morgan R, et al. (1991) Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes 40(12): 1712-1718.
17. Baroni MG, Oelbaum RS, Pozzilli P, Stocks J, Li SR, et al. (1992) Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum Genet 88(5): 557-561.
18. Pontiroli AE, Capra F, Veglia F, Ferrari M, Xiang KS, et al. (1996) Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta. Diabetologia 33(3): 193-197.
19. Matsutani A, Koranyi L, Cox N, Permutt MA (1990) Polymorphisms ofGLUT2 and GLUT4 genes. Use in evaluation of genetic susceptibility to NIDDM in blacks. Diabetes 39(12): 1534-1542.
20. Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, et al. (2003) Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J Biol Chem 19 278(51): 51779-51785.
21. Ma D, Tang XD, Rogers TB, Welling PA (2007) An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway. J Biol Chem 23 282(8): 5781-5809.
22. Wang GJ, Yang P, Xie HG (2006) Gene variants in noncoding regions and their possible consequences. Pharmacogenomics 7: 203-209.
23. Novak A, Dedhar S (1999) Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56: 523-537.
24. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, et al. (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55: 2890-2895.
25. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, et al. (2006) Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55: 2654-2659.
26. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, et al. (2006) Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55: 2649-2653.
27. Zhang C, Qi L, Hunter DJ, Meigs JB, Manson JE, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 55: 2645-2648.
28. Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, et al. (2006) Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55: 2640-2644.
29. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, et al. (2006) Diabetes Prevention Program Research Group: TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241-250.
30. Li ZZ, Lu XZ, Liu JB, Chen L (2010) Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy. J Int Med Res 38(1): 95-99.
31. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, et al. (2001) A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69: 553-569.
32. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
33. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
34. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336-1341.
35. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, et al. (2009) Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 58:1690-1699.
36. Fuu-Jen Tsai, Chi-Fan Yang, Ching-Chu Chen, Lee-Ming Chuang, Chieh-Hsiang Lu, et al. (2010) A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese. PLoS Genet 6(2): e100847.
37. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, et al. (2008) Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 40: 1092-1097.
38. Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, et al. (2008) SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 40: 1098-1102.
39. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C (2007) Epidemiology of type 2 diabetes: Indian scenario. Indian JMed Res 25: 217-230.
40. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research 16(3): 1215.
41. Shu Ye, Sahar Dhillon, Xiayi Ke, Andrew R Collins, Ian NM Day (2001) An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research 29:No. 17 e88.